Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Childhood atopic asthma immunotherapy trial
ACTRN12612000555853Phase 4Completed
- Sponsor
- Marmara University
- Start
- Mar 2007
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of fluticasone in asthma and allergic rhinitis (AR) (3 arms), sponsored by Marmara University. Primary endpoint: Clinical improvement. Started Mar 2007; status: completed.
02
Drugs
fluticasone
03
Conditions
asthmaallergic rhinitis (AR)
Beyond the preview
Go deeper on ACTRN12612000555853.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12612000555853.